The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques

Acta Radiologica

Volumn 52, Issue 2, 2011, Pages 211-222

  Li, Tie Qiang ^a   Wahlund, Lars Olof ^b  

^a Karolinska Huddinge Medical Physics   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Arterial spin labeling; Diffusion tensor imaging; Functional connectivity MRI; Functional MRI; Magnetic resonance imaging; Magnetic resonance spectroscopy; Neuroimaging biomarkers; Voxel based morphometry

Indexed keywords

ALZHEIMER'S DISEASE; ARTERIAL SPIN LABELING; DIFFUSION TENSOR IMAGING; FUNCTIONAL MRI; NEURO-IMAGING; VOXEL-BASED MORPHOMETRY;

MAGNETIC RESONANCE SPECTROSCOPY; NEURODEGENERATIVE DISEASES; RESONANCE; TENSORS;

MAGNETIC RESONANCE IMAGING;

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; BRAIN; DIFFUSION WEIGHTED IMAGING; HUMAN; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; REVIEW; SPIN LABELING; THREE DIMENSIONAL IMAGING;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; SPIN LABELS;

EID: 79958777483     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2010.100053     Document Type: Article

References (106)

1. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-105 (Pubitemid 16236926)
2. Hyman BT, Flory JE, Arnold SE, et al. Quantitative assessment of ALZ-50 immunoreactivity in Alzheimer's disease. J Geriatr Psychiatry Neurol 1991;4:231-5
3. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143-53 (Pubitemid 32405708)
4. Snowdon DA, Kemper SJ, Mortimer JA, et al. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. JAMA 1996;275:528-32 (Pubitemid 26061427)
5. DeKosky ST, Marek K. Looking backward to move forward: Early detection of neurodegenerative disorders. Science 2003;302:830-4 (Pubitemid 37339617)
6. Bertram L, Tanzi RE. Thirty years of Alzheimer's disease genetics: The implications of systematic meta-analyses. Nat Rev Neurosci 2008;9:768-78
7. Mayeux R, Saunders AM, Shea S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med 1998;338:506-11
8. Busatto GF, Diniz BS, Zanetti MV. Voxel-based morphometry in Alzheimer's disease. Expert Rev Neurother 2008;8:1691-702
9. Hampel H, Burger K, Teipel SJ, et al. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement 2008;4:38-48
10. Convit A, de Asis J, de Leon MJ, et al. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging 2000;21:19-26 (Pubitemid 30224781)
11. Rombouts SA, Barkhof F, Witter MP, et al. Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett 2000;285:231-3 (Pubitemid 30252070)
12. Lau JC, Lerch JP, Sled JG, et al. Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease. Neuroimage 2008;42:19-27
13. Mungas D, Harvey D, Reed BR, et al. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology 2005;65:565-71 (Pubitemid 41170716)
14. Duyn JH, Van Gelderen P, Li TQ, et al. High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci USA 2007;104:11796-801 (Pubitemid 47175092)
15. Fukunaga M, Li TQ, van Gelderen P, et al. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci USA 2010;107:3834-9
16. Li TQ, van Gelderen P, Merkle H, et al. Extensive heterogeneity in white matter intensity in high-resolution T2+-weighted MRI of the human brain at 7.0 T. Neuroimage 2006;32:1032-40 (Pubitemid 44308284)
17. Li TQ, Yao B, van Gelderen P, et al. Characterization of T(2) heterogeneity in human brain white matter. Magn Reson Med 2009;62:1652-7
18. Shmueli K, de Zwart JA, van Gelderen P, et al. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn Reson Med 2009;62:1510-22
19. Yao B, Li TQ, Gelderen P, et al. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage 2009;44:1259-66
20. Schacter DL,Wagner AD. Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval. Hippocampus 1999;9:7-24 (Pubitemid 29129356)
21. Schacter DL, Wagner AD. Perspectives: Neuroscience. Remembrance of things past. Science 1999;285:1503-4 (Pubitemid 29420567)
22. Bosch B, Bartres-Faz D, Rami L, et al. Cognitive reserve modulates task-induced activations and deactivations in healthy elders, amnestic mild cognitive impairment and mild Alzheimer's disease. Cortex 2010;46:451-61
23. Rombouts SA, Goekoop R, Stam CJ, et al. Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease. Neuroimage 2005;26:1078-85 (Pubitemid 40806486)
24. Wierenga CE, Bondi MW. Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease. Neuropsychol Rev 2007;17:127-43 (Pubitemid 46889567)
25. Bookheimer SY, Strojwas MH, Cohen MS, et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000;343:450-6 (Pubitemid 30646483)
26. Borghesani PR, Johnson LC, Shelton AL, et al. Altered medial temporal lobe responses during visuospatial encoding in healthy APOE4 carriers. Neurobiol Aging 2008;29:981-91 (Pubitemid 351697985)
27. Filippini N, MacIntosh BJ, Hough MG, et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci USA 2009;106:7209-14
28. Belleville S, Sylvain-Roy S, de Boysson C, et al. Characterizing the memory changes in persons with mild cognitive impairment. Prog Brain Res 2008;169:365-75 (Pubitemid 351451914)
29. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996;334:752-8 (Pubitemid 26089356)
30. Reiman EM, Chen K, Liu X, et al. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA 2009;106:6820-5
31. Fleisher AS, Houston WS, Eyler LT, et al. Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch Neurol 2005;62:1881-8 (Pubitemid 41785082)
32. Johnson SC, Ries ML, Hess TM, et al. Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults. Arch Gen Psychiatry 2007;64:1163-71 (Pubitemid 47529340)
33. Johnson SC, Schmitz TW, Trivedi MA, et al. The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J Neurosci 2006;26:6069-76 (Pubitemid 44334754)
34. Lind J, Larsson A, Persson J, et al. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: Relation to chronological age and recognition memory. Neurosci Lett 2006;396: 23-7 (Pubitemid 43233781)
35. Machulda MM, Ward HA, Borowski B, et al. Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 2003;61:500-6 (Pubitemid 37025367)
36. Petrella JR, Wang L, Krishnan S, et al. Cortical deactivation in mild cognitive impairment: High-field-strength functional MR imaging. Radiology 2007;245:224-35 (Pubitemid 47417806)
37. Small SA, Perera GM, DeLaPaz R, et al. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann Neurol 1999;45:466-72 (Pubitemid 29165813)
38. Trivedi MA, Schmitz TW, Ries ML, et al. Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: A cross-sectional study. BMC Med 2006;4:1
39. Biswal B, Yetkin FZ, Haughton VM, et al. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 1995;34:537-41
40. Waites AB, Stanislavsky A, Abbott DF, et al. Effect of prior cognitive state on resting state networks measured with functional connectivity. Hum Brain Mapp 2005;24:59-68 (Pubitemid 40066724)
41. Greicius MD, Srivastava G, Reiss AL, et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI. Proc Natl Acad Sci USA 2004;101:4637-42 (Pubitemid 38437463)
42. Greicius MD, Supekar K, Menon V, et al. Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb Cortex 2009;19:72-8
43. He Y, Wang L, Zang Y, et al. Regional coherence changes in the early stages of Alzheimer's disease: A combined structural and resting-state functional MRI study. Neuroimage 2007;35:488-500 (Pubitemid 46400540)
44. Li SJ, Li Z, Wu G, et al. Alzheimer Disease: Evaluation of a functional MR imaging index as a marker. Radiology 2002;225:253-9
45. Wang L, Zang Y, He Y, et al. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: Evidence from resting state fMRI. Neuroimage 2006;31:496-504 (Pubitemid 43776683)
46. Zhang HY, Wang SJ, Xing J, et al. Detection of PCC functional connectivity characteristics in resting-state fMRI in mild Alzheimer's disease. Behav Brain Res 2009;197:103-8
47. Raichle ME, MacLeod AM, Snyder AZ, et al. A default mode of brain function. Proc Natl Acad Sci USA 2001;98:676-82 (Pubitemid 32105102)
48. Gusnard DA, Raichle ME, Raichle ME. Searching for a baseline: Functional imaging and the resting human brain. Nat Rev Neurosci 2001;2:685-94 (Pubitemid 33674814)
49. Fransson P. Spontaneous low-frequency BOLD signal fluctuations: An fMRI investigation of the resting-state default mode of brain function hypothesis. Hum Brain Mapp 2005;26:15-29 (Pubitemid 41232552)
50. Raichle ME, Mintun MA. Brain work and brain imaging. Annu Rev Neurosci 2006;29:449-76 (Pubitemid 44476853)
51. Rombouts S, Scheltens P. Functional connectivity in elderly controls and AD patients using resting state fMRI: A pilot study. Curr Alzheimer Res 2005;2:115-6 (Pubitemid 40862870)
52. Sorg C, Riedl V, Muhlau M, et al. Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci USA 2007;104:18760-5 (Pubitemid 350210770)
53. Sorg C, Valentin R, Robert P, et al. Impact of Alzheimer's disease on the functional connectivity of spontaneous brain activity. Curr Alzheimer Res 2009;6:541-53
54. Wang K, Liang M, Wang L, et al. Altered functional connectivity in early Alzheimer's disease: A resting-state fMRI study. Hum Brain Mapp 2007;28:967-78 (Pubitemid 47549702)
55. Wermke M, Sorg C,Wohlschlager AM, et al. A new integrative model of cerebral activation, deactivation and default mode function in Alzheimer's disease. Eur J Nucl Med Mol Imaging 2008;35 (Suppl. 1):S12-24
56. Hutchinson M, Schiffer W, Joseffer S, et al. Task-specific deactivation patterns in functional magnetic resonance imaging. Magn Reson Imaging 1999;17:1427-36
57. Lustig C, Snyder AZ, Bhakta M, et al. Functional deactivations: Change with age and dementia of the Alzheimer type. Proc Natl Acad Sci USA 2003;100:14504-9 (Pubitemid 37499266)
58. Meltzer JA, Negishi M, Constable RT. Biphasic hemodynamic responses influence deactivation and may mask activation in block-design fMRI paradigms. Hum Brain Mapp 2008;29:385-99 (Pubitemid 351522133)
59. Mozolic JL, Joyner D, Hugenschmidt CE, et al. Cross-modal deactivations during modality-specific selective attention. BMC Neurol 2008;8:35
60. Kawashima R, O'Sullivan BT, Roland PE "Positron-emission tomography studies of cross-modality inhibition in selective attentional tasks : Closing the mind's eye". Proc Natl Acad Sci USA 1995;92:5969-72
61. Drzezga A, Grimmer T, Peller M, et al. Impaired cross-modal inhibition in Alzheimer disease. PLoS Med 2005;2:e288
62. Celone KA, Calhoun VD, Dickerson BC, et al. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: An independent component analysis. J Neurosci 2006;26:10222-31 (Pubitemid 44527415)
63. Damoiseaux JS, Rombouts SA, Barkhof F, et al. Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci USA 2006;103:13848-53 (Pubitemid 44413996)
64. Maxim V, Sendur L, Fadili J, et al. Fractional Gaussian noise, functional MRI and Alzheimer's disease. Neuroimage 2005;25:141-58 (Pubitemid 40289145)
65. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992;23:37-45
66. Williams DS, Detre JA, Leigh JS, et al. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci USA 1992;89:212-6
67. Li TQ, Moseley ME, Glover G. A FAIR study of motor cortex activation under normo- and hypercapnia induced by breath challenge. Neuroimage 1999;10:562-9
68. Bangen KJ, Restom K, Liu TT, et al. Differential age effects on cerebral blood flow and BOLD response to encoding: Associations with cognition and stroke risk. Neurobiol Aging 2009;30:1276-87
69. Restom K, Bangen KJ, Bondi MW, et al. Cerebral blood flow and BOLD responses to a memory encoding task: A comparison between healthy young and elderly adults. Neuroimage 2007;37:430-9 (Pubitemid 47444260)
70. Fleisher AS, Podraza KM, Bangen KJ, et al. Cerebral perfusion and oxygenation differences in Alzheimer's disease risk. Neurobiol Aging 2009;30:1737-48
71. Kofke WA, Blissitt PA, Rao H, et al. Remifentanil-induced cerebral blood flow effects in normal humans: Dose and ApoE genotype. Anesth Analg 2007;105:167-75 (Pubitemid 46975863)
72. Dai W, Lopez OL, Carmichael OT, et al. Mild cognitive impairment and alzheimer disease: Patterns of altered cerebral blood flow at MR imaging. Radiology 2009;250:856-66
73. Johnson NA, Jahng GH, Weiner MW, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: Initial experience. Radiology 2005;234:851-9 (Pubitemid 40250829)
74. Luckhaus C, Flub MO, Wittsack HJ, et al. Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging. Neuroimage 2008;40:495-503
75. Alsop DC, Casement M, de Bazelaire C, et al. Hippocampal hyperperfusion in Alzheimer's disease. Neuroimage 2008;42:1267-74
76. Asllani I, Habeck C, Scarmeas N, et al. Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease. J Cereb Blood Flow Metab 2008;28:725-36 (Pubitemid 351432785)
77. Du AT, Jahng GH, Hayasaka S, et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology 2006;67:1215-20 (Pubitemid 44563830)
78. Robson PM, Madhuranthakam AJ, Dai W, et al. Strategies for reducing respiratory motion artifacts in renal perfusion imaging with arterial spin labeling. Magn Reson Med 2009;61:1374-87
79. DaiW, Garcia D, de Bazelaire C, et al. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008;60:1488-97
80. Li TQ, Chen ZG, Hindmarsh T. Diffusion-weighted MR imaging of acute cerebral ischemia. Acta Radiol 1998;39:460-73 (Pubitemid 128456043)
81. Li TQ, Takahashi AM, Hindmarsh T, et al. ADC mapping by means of a single-shot spiral MRI technique with application in acute cerebral ischemia. Magn Reson Med 1999;41:143-7 (Pubitemid 29068046)
82. Skare S, Hedehus M, Moseley ME, et al. Condition number as a measure of noise performance of diffusion tensor data acquisition schemes with MRI. J Magn Reson 2000;147:340-52
83. Chen SQ, Kang Z, Hu XQ, et al. Diffusion tensor imaging of the brain in patients with Alzheimer's disease and cerebrovascular lesions. J Zhejiang Univ Sci B 2007;8:242-7
84. Cho H, Yang DW, Shon YM, et al. Abnormal integrity of corticocortical tracts in mild cognitive impairment: A diffusion tensor imaging study. J Korean Med Sci 2008;23:477-83
85. Ding B, Chen KM, Ling HW, et al. Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008;25:218-25 (Pubitemid 351363885)
86. Duan JH, Wang HQ, Xu J, et al. White matter damage of patients with Alzheimer's disease correlated with the decreased cognitive function. Surg Radiol Anat 2006;28:150-6
87. Fellgiebel A, Wille P, Muller MJ, et al. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: A diffusion tensor imaging study. Dement Geriatr Cogn Disord 2004;18:101-8 (Pubitemid 38822746)
88. Zhang Y, Schuff N, Jahng GH, et al. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007;68:13-9 (Pubitemid 46058544)
89. Huang J, Friedland RP, Auchus AP. Diffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer disease: Preliminary evidence of axonal degeneration in the temporal lobe. Am J Neuroradiol 2007;28:1943-8 (Pubitemid 350174740)
90. Kiuchi K, Morikawa M, Taoka T, et al. Abnormalities of the uncinate fasciculus and posterior cingulate fasciculus in mild cognitive impairment and early Alzheimer's disease: A diffusion tensor tractography study. Brain Res 2009;1287:184-91
91. Mielke MM, Kozauer NA, Chan KC, et al. Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neuroimage 2009;46:47-55
92. Stenset V, Bjornerud A, Fjell AM, et al. Cingulum fiber diffusivity and CSF T-tau in patients with subjective and mild cognitive impairment. Neurobiol Aging 2 2009;30:1737-48
93. Stahl R, Dietrich O, Teipel S, et al. [Assessment of axonal degeneration on Alzheimer's disease with diffusion tensor MRI]. Radiologe 2003;43:566-75 (Pubitemid 36966296)
94. Honea RA, Vidoni E, Harsha A, et al. Impact of APOE on the Healthy Aging Brain: A Voxel-Based MRI and DTI Study. J Alzheimers Dis 2009;18:553-64
95. Choi C, Dimitrov I, Douglas D, et al. In vivo detection of serine in the human brain by proton magnetic resonance spectroscopy (1H-MRS) at 7 Tesla. Magn Reson Med 2009;62:1042-6
96. Dixon RM, Bradley KM, Budge MM, et al. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain 2002;125:2332-41
97. Schuff N, Amend D, Ezekiel F, et al. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology 1997;49:1513-21 (Pubitemid 28015109)
98. Miller BL, Moats RA, Shonk T, et al. Alzheimer disease: Depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993;187:433-7 (Pubitemid 23127850)
99. Kantarci K, Jack CR Jr. Neuroimaging in Alzheimer disease: An evidence-based review. Neuroimaging Clin N Am 2003;13:197-209 (Pubitemid 36791507)
100. Kantarci K, Jack CR Jr, Xu YC, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology 2000;55:210-7 (Pubitemid 30604620)
101. Kantarci K, Petersen RC, Boeve BF, et al. 1H MR spectroscopy in common dementias. Neurology 2004;63:1393-8
102. Kantarci K, Weigand SD, Petersen RC, et al. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2007;28:1330-9 (Pubitemid 47081237)
103. Wang Z, Zhao C, Yu L, et al. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease. Acta Radiol 2009;50:312-9
104. Kantarci K, Petersen RC, Przybelski SA, et al. Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes. Arch Neurol 2008;65:1621-8
105. Mueller SG, Schuff N, Weiner MW. Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS. NMR Biomed 2006;19:655-68 (Pubitemid 44515610)
106. Li TQ, Yao B, van Gelderen P, eds. Cortical architecture of the human hippocampus studied by high-resolution susceptibility-weighted MRI at 7T. Toronto: ISMMR, 2008:2219